1. Introduction {#sec1}
===============

Clinical TB remains a major global health problem and the second leading cause of death from an infectious disease worldwide. TB has a global incidence of 8.6 million, a mortality of 1.3 million, and sadly a global treatment success rate of only 87% \[[@B1]\]. Studies are carried out on TB and HIV in almost every aspect so as to develop new or improved systems in the early diagnosis and control of the comorbidity. The laboratory markers associated with PTB with or without HIV coinfection play a major role, although a nonspecific one, in the diagnosis and prognosis of TB in patients \[[@B2], [@B3]\]. The demonstrable changes that PTB + HIV, PTB, and HIV seropositive patients have in their hematological and metabolic values all in all showed varied pictures in each study as a result of the phase of the infection and the causative agents, namely,*Mycobacterium tuberculosis* and*Human Immune Deficiency Virus* \[[@B2]\].

Guyana, a lower-middle-income country being ranked as one of the TB high-burden countries in the Americas, sustains a tuberculosis (TB) prevalence (including HIV) of 131 for every 100,000 persons in 2012 \[[@B1]\]. In Guyana, 28% of tested TB patients are diagnosed as HIV coinfected \[[@B4]\]. The country is very vulnerable to the devastating impact of HIV/AIDS due to the most productive age groups (15--49 years) in society being affected with 1.4% in 2013 \[[@B5]\].

Tuberculosis and HIV are devastating infectious diseases associated with a low socioeconomic status, with the reputation of bringing stigma and discrimination to their victims and inflicting economic losses to low- and middle-income nations \[[@B6], [@B7]\]. Both drug resistance and HIV worsen the TB disease burden among individuals and are a threat to global TB control. Although nondefinitive, some routine clinical laboratory assays can be useful in assisting diagnosis and prognosis at a low cost, but care must be taken while interpreting them due to other confounding factors such as drug induced or viral hepatitis, diabetes coinfection, and age.

The purpose of this study is to observe the hematological and biochemical status of pulmonary tuberculosis (PTB) patients with or without Human Immune Deficiency Virus (HIV) coinfection at the Chest Clinic, Georgetown Public Hospital, Guyana.

2. Methods {#sec2}
==========

2.1. Study Site and Population {#sec2.1}
------------------------------

An observational, laboratory based retrospective descriptive study was designed to assess the relationship of PTB and HIV with patients routine biochemical and hematological values. The study was conducted during the period January 2013 to December 2014 at Georgetown Chest Clinic, Guyana. Sample sizes of 316 patients were enrolled following exclusion and inclusion criteria.

*Inclusion Criterion.* All patients who were diagnosed of PTB and PTB + HIV with no past history of TB were considered for the present study.

*Exclusion Criteria.* Patients with the following conditions were excluded from the study:patients under inspection;patients with any type of hepatitis complications at the time of PTB diagnosis;inadequate medical records to allow complete analysis;pregnancy at time of PTB diagnosis;patients with a clinical history of chronic renal failure;hemoglobinopathy;neoplastic disease and collagen vascular disease;deceased patients upon follow-up;malaria and worm infested PTB diagnosis;sputum sample taken after initiation of treatment.

2.2. Laboratory Testing {#sec2.2}
-----------------------

Patients suspected of pulmonary tuberculosis were tested using fluorescence microscopy and treatment begins as soon as PTB is confirmed. An HIV test is done, if patients HIV status is unknown at the time and a RBS is taken to screen for diabetes. CD4 count and sputum smear grade were also investigated. Hematology and biochemistry tests of the patients were performed at the Georgetown Public Hospital Cooperation (GPHC) Laboratory. Parameters evaluated for biochemistry were serum BUN, serum creatinine, serum electrolytes (K^+^, Cl^−^, and Na^+^), aspartate aminotransferase (AST), alanine aminotransferase (ALT), direct bilirubin, total bilirubin, and indirect bilirubin. Hematology parameters evaluated were fasting blood sugar (FBS), hemoglobin concentration, total white blood cell (WBC), and platelet count. Voluntary counselling and general physical evaluation of all the patients were carried out at the center. The patients were then asked questions to determine risk factors, habits, and sociodemographic data (age, gender, ethnicity, education, smoking history, and alcohol intake).

2.3. Ethical Considerations {#sec2.3}
---------------------------

The study was approved by the University of Guyana, Guyana. Permission was also obtained from the Institutional Review Board (IRB), Ministry of Health, Guyana, to proceed with the study. Individual patients were assigned numbers for identification.

2.4. Statistical Analysis {#sec2.4}
-------------------------

All pieces of information were first entered in Excel spreadsheet and later transferred to SPSS 20.0 and JMP for further analysis.

3. Results {#sec3}
==========

3.1. Patient Selection Profile {#sec3.1}
------------------------------

A total of 495 TB patients that were not under investigation were selected by the National Tuberculosis Program (NTP) staff. Of these, 37 had Extrapulmonary Tuberculosis (EPTB), 23 had both pulmonary tuberculosis (PTB) and EPTB, 1 had liver disease, 3 females were pregnant, 10 had malaria within a year, before TB diagnosis, and 105 had too little or no lab test available.

3.2. Background Characteristics {#sec3.2}
-------------------------------

A total of 316 patients with newly diagnosed pulmonary TB were selected for the study, 235 (74.4%, 95% CI 69.3--78.8) were males and 81 (25.6%, 95% CI 21.1--30.7) were females (*p* \< 0.001). The mean age ± SD of subjects was 40.2 ± 13.8 years (95% CI 38.6--41.7). Median age and standard error (SE) and interquartile range (IQR) of the study population were 40 ± 0.77 and 20, respectively ([Table 1](#tab1){ref-type="table"}).

Of the total 316 patients, 44 (13.9% 95% CI 10.5--18.2) were HIV positive and 272 (86.1%, 95% CI 81.8--89.5) were HIV negative with *p* \> 0.05. Among those coinfected with PTB-HIV, a significant proportion (62.5%, 95% CI 47.0--75.7) had a CD4 count \<200 (*p* \< 0.001). A significant higher number (30.0%, 95% CI 25.3--35.3) of patients had a sputum grade of 3+ (*p* \< 0.001) ([Table 2](#tab2){ref-type="table"}).

3.3. Hematology Results {#sec3.3}
-----------------------

Tables [3](#tab3){ref-type="table"} and [4](#tab4){ref-type="table"} show the number (percentage), mean, and 95% CI of the hematological parameters among the study population. Significant high parameters were found among TB-HIV coinfected population.

3.4. Biochemistry Results {#sec3.4}
-------------------------

[Table 5](#tab5){ref-type="table"} shows the number (percentage), mean, and 95% CI of biochemical parameters among the study population. Most biochemistry parameters had significant high values among TB-HIV coinfected population.

3.5. Risk Factors {#sec3.5}
-----------------

[Table 6](#tab6){ref-type="table"} demonstrates the different risk factors associated with the study population. Patients at particular risk of the TB/TB-HIV were males and homeless. Significant risk factors demonstrated within the study population were diabetes 14.9% (95% CI 11.4--19.3), HTN 3.5% (95% CI 1.9--6.1), allergy 2.8% (95% CI 1.5--5.3), homelessness 0.09 (95% CI 0.03--2.7), being alcoholic 34.2% (95% CI 29.2--39.6), and smoking 32.9 (95% CI 27.9--38.7) (*p* \< 0.001).

4. Discussion {#sec4}
=============

This study was a first-time effort to relate hematological and biochemistry parameters among TB patients with or without HIV at the Georgetown Chest Clinic, Guyana. Though this study did not have enough TB-HIV coinfected patients, a concrete conclusion cannot be made.

Our study reveals that men were most infected than females and 51% of patients being between the ages of 30 years and 49 years which is a normal trend seen in most parts of the world \[[@B8], [@B9]\]. This study demonstrated significant high number with CD~4~ \> 200. CD~4~ and CD~8~ T-cells are important immune components against TB and HIV and reduction in the count could suppress the immunity of the patient \[[@B10]\].

Some studies agree that the mean of the total WBC count in PTB patients is usually normal or not significantly elevated as compared to the normal mean of a population \[[@B11], [@B12]\]. However, Amilo et al. state that there is a statistically higher total WBC count among PTB and PTB-HIV comorbid patients, where neutrophilia is the main contributor to the increase \[[@B2]\]. Platelets are effector cells that play an important role in the inflammatory and immunological response and have the capacity to release cytokines and chemokines, thus acting as an immune regulator \[[@B13]\]; therefore this direct relationship between platelet and WBC is logical because when there is an immune response at PTB infection, platelets tend to increase.

This study did not show any variation on blood sugar although Bailey and Grant \[[@B6]\] found that the relationship that exists between diabetes and tuberculosis has even been shown to be more significant than that of HIV/AIDS with TB, although it is not consistently reproduced in different populations \[[@B14]\].

Risk factors play a major role in the magnitude of TB and HIV. There were many risk factors involved in this study, but the magnitude of TB was high among the homeless, smokers, and males. Socioeconomic status is always a major risk factor \[[@B15]\].

There are several limitations that might have affected our conclusions; first, analysis was done based on the data available from the Chest Clinic. Second, a large-scale cross-sectional study might have produced a better conclusion on the laboratory parameters. Finally, other risk factors could have also included in this study.

5. Conclusion {#sec5}
=============

Hematological and biochemistry parameters are important, simple, and cheaper method in analyzing the pattern of health status among PTB patients with or without HIV.
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###### 

Characteristics of study population in the Georgetown Chest Clinic, Guyana.

  ----------------------------------------------------------------------------------------------------------------------
  Characteristics   Total population\   95% CI            TB\           95% CI            TB-HIV\       95% CI
                    *n* = 316                             272 (86.1)                      44 (13.9)     
  ----------------- ------------------- ----------------- ------------- ----------------- ------------- ----------------
  Age (mean ± SD)   40 ± 13.8           38.6--41.7        40.0 ± 14.3   38.3--41.7        40.9 ± 10.7   37.7--44.2

  Age group                                                                                              

   \<20             20 (6.3)            4.1--9.6          20 (7.4)      4.8--11.1         0              

   20--29           59 (18.7)           14.8--23.3        52 (19.1)     14.9--24.2        7 (15.9)      7.9--29.3

   30--39           74 (23.4)           19.1--28.4        57 (21.0)     16.5--26.2        17 (38.6)     25.7--53.3

   40--49           88 (27.8)           23.2--33.0        77 (28.3)     23.3--33.9        11 (25.0)     14.6--39.4

   50--59           45 (14.2)           10.8--18.5        39 (14.3)     10.7--19.0        6 (13.6)      6.4--26.7

   \>60             30 (9.5)            6.7--13.2         27 (9.9)      6.9--14.1         3 (6.8)       2.3--18.2

                                        **p** \< 0.0001                 **p** \< 0.0001                 **p** \< 0.05

  Gender                                                                                                 

   Male             235 (74.4)          69.3--78.8        201 (73.9)    68.4--78.7        34 (77.3)     63.0--87.1

   Female           81 (25.6)           21.1--30.7        71 (26.1)     21.2--31.6        10 (22.7)     12.8--36.9

                                        **p** \< 0.0001                 **p** \< 0.0001                 **p** \< 0.001

  Ethnicity                                                                                              

   Afro-Guyanese    131 (41.5)          36.2--47.0        101 (37.1)    31.6--43.0        30 (68.2)     53.4--80.0

   Amerindian       33 (10.4)           7.5--14.3         31 (11.4)     8.1--15.7         2 (4.5)       1.3--15.1

   Indo-Guyanese    71 (24.5)           18.2--27.4        68 (25.0)     20.2--30.5        3 (6.8)       2.3--18.2%

   Mixed            77 (24.4)           20.0--29.4        68 (25.0)     20.2--30.5        9 (2.0)       2.0--11.1%

   Portuguese       4 (1.3)             0.5--3.2          4 (1.5)       0.5--3.7          0.0            

                                        **p** \< 0.0001                 **p** \< 0.0001                 **p** \< 0.001
  ----------------------------------------------------------------------------------------------------------------------

###### 

Hematological parameters among TB and TB-HIV patients.

                HIV serostatus                                                
  ------------- ----------------- ------------ ----------------- ------------ -------------
  Hb                                                                           
   Low          80.2% (200)       74.9--84.8   91.7% (33)        78.2--97.1   81.8% (233)
   Normal       19.6% (49)        15.2--25.0   0.08% (3)         2.8--2.2     18.3% (52)
                **p** \< 0.0001                **p** \< 0.0001                 
  WBC                                                                          
   High         17.0% (42)        12.8--22.2   2.8% (1)          0.5--14.2    15.2% (43)
   Low          5.3% (13)         3.1--8.7     27.8% (10)        15.8--44.0   8.1% (23)
   Normal       77.7% (192)       72.2--82.5   69.4% (25)        53.1--82.0   76.7% (217)
                **p** \< 0.0001                **p** \< 0.0001                 
  PLT                                                                          
   High         27.3% (30)        19.8--36.2   12.5% (2)         3.5--36.0    25.6% (32)
   Low          4.5% (5)          1.9--10.2    6.3% (1)          1.1--28.3    4.8% (6)
   Normal       68.2% (75)        58.9--76.1   81.3% (13)        56.9--93.4   69.6% (87)
                **p** \< 0.0001                **p** \< 0.0001                 
  Blood sugar                                                                  
   High         37.7% (91)        31.8--44.0   3.1% (12)         1.9--4.7     36.9% (103)
   Low          4.5% (11)         2.5--7.9     0.3% (1)          0.04--13.4   4.3% (12)
   Normal       57.7% (139)       51.4--63.7   65.7% (25)        49.8--78.7   58.8% (164)

###### 

Mean and SD of hematological parameters among TB and TB-HIV patients.

                Reference value       HIV positive   HIV negative                     
  ------------- --------------------- -------------- ---------------- --------------- ----------------
  Blood sugar                                                                          
  FBS (mg/dL)   70--105                                                                
   Male                               95.3 ± 16.9    (68.3--122.2)    121.3 ± 79.9    (96.6--146.0)
   Female                             0                               118.9 ± 58      (87.9--149.8)
    *p* value                         \<0.001                         \<0.001          
  RBS (mg/dL)   70--120                                                                
   Male                               122.6 ± 47.4   (103.1--142.2)   132.1 ± 75.1    (119.7--144.6)
   Female                             101.4 ± 14.6   (90.2--112.6)    123.7 ± 66.3    (104.6--142.7)
    *p* value                         \<0.001                         \<0.001         (7.7--8.7)
  WBC           4--11 (10^3^/uL)      5.5 ± 1.7      (4.6--6.3)       8.2 ± 3.5        
    *p* value                         \<0.001                         \<0.001          
  PLT           150--450 (10^3^/uL)   260.4 ± 146    (194.4--326.4)   376.3 ± 173.3   (343.6--409.1)
    *p* value                         \<0.001                         \<0.001          

###### 

Biochemistry parameters among TB and TB-HIV patients.

                               Reference value   HIV positive   HIV negative                 
  ---------------------------- ----------------- -------------- -------------- ------------- --------------
  Indirect bilirubin (mg/dL)   0.1--1.0          0.4 ± 0.3      0.4--0.6       0.41 ± 0.25   0.36--0.44
  T-bilirubin (mg/dL)          0.2--1.2          0.7 ± 0.3      0.59--0.79     0.68 ± 0.7    0.58--0.77
  D-bilirubin (mg/dL)          0.0--0.5          0.26 ± 0.2     0.20--0.31     0.24 ± 0.24   0.21--0.27
  AST (IU/L)                   5--34             64.6 ± 61.9    45.5--83.6     37.9 ± 38.2   33.2--42.6
  ALT (IU/L)                   4--36             45.6 ± 49.9    30.2--60.9     35.2 ± 45.8   29.6--40.8
  Cl (mmol/L)                  98--107           101.5 ± 4.7    99.4--103.6    101.1 ± 4.4   100.4--101.7
  Na (mmol/L)                  135--148          136 ± 3.4      134.8--137.8   137.7 ± 3.4   137.1--138.2
  K (mmol/L)                   3.5--5.3          4.2 ± 0.6      3.9--4.4       4.2 ± 0.4     4.1--4.3
  Creatinine (mg/dL)           0.4--1.4          0.96 ± 0.43    0.83--1.1      1.0 ± 1.5     0.8--1.2
  BUN (mg/dL)                  7--18             12.4 ± 5.6     10.6--14.1     11.7 ± 5.3    11.0--12.3

###### 

Mean and SD of biochemistry parameters among TB and TB-HIV patients.

                       HIV serostatus                                          
  -------------------- ---------------- ------------ ------------ ------------ -------------
  Indirect bilirubin                                                            
   High                2.8% (4)         1.1--7.2     7.4% (2)     2.1--23.3    3.6% (6)
   Normal              97.1% (134)      92.7--98.8   92.5% (25)   76.6--97.9   96.4% (159)
  T-bilirubin                                                                   
   High                5.4% (12)        3.1--9.2     5.0% (2)     1.4--1.7     5.4% (14)
   Normal              94.6% (209)      90.7--96.7   95.0% (38)   83.5--98.6   94.6% (247)
  D-bilirubin                                                                   
   High                1.7% (4)         0.6--4.3     7.1% (3)     2.5--19.0    2.5% (7)
   Normal              98.3% (230)      95.7--99.3   92.8% (39)   80.9--97.5   97.5% (269)
  AST                                                                           
   High                35.2% (91)       29.9--41.2   72.1% (31)   57.3--83.3   40.5% (122)
   Normal              64.7% (167)      58.7--70.3   27.9% (12)   16.7--42.7   59.5% (179)
  ALT                                                                           
   High                23.3% (60)       18.5--28.7   41.8% (18)   28.4--56.7   25.9% (78)
   Normal              76.7% (198)      71.2--81.5   58.1% (25)   43.3--71.6   74.1% (223)
  Cl                                                                            
   High                1.9% (3)         0.06--5.6    0.6% (1)     0.08--21.7   2.3% (4)
   Low                 17.86% (27)      12.6--24.7   2.9% (5)     10.1--43.4   18.5% (32)
   Normal              80.1% (121)      73.0--85.7   9.3% (16)    51.8--86.8   79.2% (137)
  K                                                                             
   High                1.3% (2)         0.03--4.7    4.5% (1)     0.08--21.7   1.7% (3)
   Low                 1.7% (27)        1.2--2.5     22.7% (5)    10.1--43.4   4.1% (7)
   Normal              80.7% (122)      73.7--86.3   72.7% (16)   51.8--86.8   94.2% (163)
  Na                                                                            
   High                1.3% (2)         0.03--4.7    4.5% (1)     0.08--21.7    
   Low                 17.9% (27)       12.6--24.8   22.7% (5)    10.1--43.4   20.2% (35)
   Normal              80.8% (122)      73.7--86.3   72.7% (16)   51.8--86.8   79.8% (138)
  Creatinine                                                                    
   High                8.6% (22)        5.7--12.7    11.6% (5)    5.1--24.5    9.10%
   Low                 0.04% (1)        0.006--0.2   0.0% (0)     0            0.3% (1)
   Normal              90.9% (232)      86.8--93.9   88.3% (38)   75.5--94.9   90.6% (270)
  BUN                                                                           
   High                8.4% (21)        5.6--12.5    9.5% (4)     3.7--22.0    8.6% (25)
   Low                 8.8% (22)        8.8--13.0    9.5% (4)     3.7--22.0    8.9% (26)
   Normal              82.7% (206)      77.5--86.9   80.9% (34)   66.6--90.0   82.5% (240)

###### 

Risk factors associated with TB patients with HIV positive and negative.

                                 HIV positive   HIV negative        OR (95% CI)         RR (95% CI)
  ----------------- ------------ -------------- ------------------- ------------------- -------------------
  Diabetes          Yes          3 (0.95%)      44 (14.0%)          0.38 (0.11--1.27)   0.42 (0.13--1.29)
  No                41 (13.0%)   227 (72.1%)                                            
                                                                                        
  HTN               Yes          0              11 (3.5%)                                
  No                44 (13.9%)   261 (82.6%)    0                                       
                                                                                        
  Allergy           Yes          0              9 (2.9%)                                 
  No                44 (13.9%)   263 (83.2%)    0                                       
                                                                                        
  Homelessness      Yes          1 (0.3%)       2 (0.6%)                                 
  No                43 (13.6%)   270 (85.4%)    3.14 (0.28--35.4)   2.4 (0.48--12.3)    
                                                                                        
  Being alcoholic   Yes          13 (4.1%)      95 (30.1%)                               
  No                31 (9.8%)    177 (56.0%)    0.78 (0.4--1.6)     0.81 (0.44--1.48)   
                                                                                        
  Smoking           Yes          9 (2.9%)       95 (30.1%)                               
  No                35 (11.1%)   177 (56.0%)    0.48 (0.22--1.04)   1.09 (1.01--1.19)   
                                                                                        
  Substance abuse   Yes          6 (1.9%)       42 (13.3%)                               
  No                38 (12.0%)   230 (72.8%)    0.86 (0.34--0.22)   0.89 (0.39--1.97)   
                                                                                        
  TB contact        Yes          9 (2.9%)       55 (17.4%)                               
  No                35 (11.1%)   217 (68.7%)    1.0 (0.46--2.24)    1.0 (0.5--2.0)      
                                                                                        
  Gender            Female       10 (3.2%)      71 (22.5%)                               
  Male              34 (10.8%)   201 (63.6%)    1.20 (0.56--2.56)   1.2 (0.61--2.26)    

[^1]: Academic Editor: Jacques Grosset
